m+Medelevator.RU
← Поиск публикаций
Translational andrology and urology · 2026

Present research and emerging trends in neurogenic bladder research: a bibliometric and visualization analysis (2015-2025).

СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Peng Yangyao, Huang Jingjing, Peng Mufeng, Wang Yingxia, Gao Gai, Zhang Qing

Аннотация

BACKGROUND: The clinical significance of neurogenic bladder (NB) has gained growing attention in recent years, attracting substantial scholarly interest. This study systematically examines collaborative research networks, evaluates emerging trends, identifies current research priorities, and projects future directions in the field of NB.

METHODS: A systematic search of the Web of Science Core Collection (WoSCC) was performed to identify relevant studies on NB published between January 2015 and June 2025. Bibliometric analysis was conducted using CiteSpace to visualize and compare contributions across countries, institutions, journals, references, and keywords.

RESULTS: The final analysis incorporated 4,180 publications, demonstrating a consistent upward trend in annual research output. The USA and the Assistance Publique-Hopitaux de Paris (AP-HP) were the top publishing countries and institutions, with 1,314 and 151 papers, respectively. "Neurourology and Urodynamics" had the highest number of publications, totaling 442, while "Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology" was the most cited reference, with 115 citations. The most prolific author was Hann-Chorng Kuo with 87 papers.

CONCLUSIONS: NB research demonstrates rapid development, yet high-quality outcomes remain scarce. Current studies primarily focus on fundamental mechanisms and technological innovation, with urgent needs to enhance clinical translation and patient-centered outcomes. Future strategies should prioritize resource optimization and multidisciplinary collaboration to accelerate translational breakthroughs while reinforcing patient-centric research frameworks.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты